Home › Funds › HORIZON KINETICS ASSET MANAGEMENT LLC › RPRX

HORIZON KINETICS ASSET MANAGEMENT LLC position in RPRX

ROYALTY PHARMA PLC · Health Care

HORIZON KINETICS ASSET MANAGEMENT LLC reported holding 353,191 shares of RPRX (ROYALTY PHARMA PLC) in its Q3 2026 13F filing — a position valued at US$20.6M, representing 0.26% of its reported portfolio and ranking #40 among its reported holdings. HORIZON KINETICS ASSET MANAGEMENT LLC has disclosed RPRX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)353.19K sh
Reported value held$20.61M
Portfolio Weight0.26%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How HORIZON KINETICS ASSET MANAGEMENT LLC's RPRX position evolved

HORIZON KINETICS ASSET MANAGEMENT LLC first disclosed a stake in RPRX in Q3 2023 at 287,255 shares (US$7.8M). The position peaked in Q3 2026 at 353,191 shares, worth US$20.6M. Across 13 filings, HORIZON KINETICS ASSET MANAGEMENT LLC increased the stake 6 time(s), trimmed it 3 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 353,191 shares valued at US$20.6M — an increase of 8,330 shares quarter over quarter.. Notable position changes include a 40% increase in Q4 2024 (shares rose 22% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 287.25K $7.80M New
Q4 2023 216.69K $6.09M Reduce
Q1 2024 200.29K $6.08M Reduce
Q2 2024 228.78K $6.03M Add
Q3 2024 228.80K $6.47M Hold
Q4 2024 319.18K $8.14M Add
Q1 2025 329.57K $10.26M Add
Q2 2025 353.47K $12.74M Add
Q3 2025 354.69K $12.51M Hold
Q4 2025 353.36K $13.65M Hold
Q1 2026 340.78K $16.35M Reduce
Q2 2026 344.86K $19.34M Add
Q3 2026 353.19K $20.61M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RPRX and 13F data

RPRX (ROYALTY PHARMA PLC) is a Health Care company. 48 other funds we track also report a position in RPRX — the largest reported positions include Swedbank AB (US$598.8M), Baillie Gifford & Co (US$534.1M), ROYAL LONDON ASSET MANAGEMENT LTD (US$348.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RPRX

All RPRX fund holders →

FAQ

How long has HORIZON KINETICS ASSET MANAGEMENT LLC held RPRX?

HORIZON KINETICS ASSET MANAGEMENT LLC has disclosed RPRX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is HORIZON KINETICS ASSET MANAGEMENT LLC's current position in RPRX?

As of Q3 2026, HORIZON KINETICS ASSET MANAGEMENT LLC holds 353.19K shares of RPRX (ROYALTY PHARMA PLC), valued at $20.61M, representing 0.26% of its reported portfolio and ranking #40.

Has HORIZON KINETICS ASSET MANAGEMENT LLC been buying or selling RPRX?

In the latest 13F filing (Q3 2026), HORIZON KINETICS ASSET MANAGEMENT LLC increased its position in RPRX. The position peaked in Q3 2026 at 353.19K shares.

Which other funds hold RPRX?

Other major institutional holders of RPRX include Swedbank AB, Baillie Gifford & Co, ROYAL LONDON ASSET MANAGEMENT LTD, among 48 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.